1Ikonomidou C, Bosch F, Miksa M, et al, Blockade of NMDA re- cepstors and apoptotic neum-degeneration in the developing brain. Science, 1999,283 ( 5398 ) :70-74.
2Scalier AC, Schmued LC, Slikker W Jr, et al. Developmental ner- mtoxicity of ketamine : mor-phometric confirmation, exposure param- eters, and multiple fluorescent fluorescent labeling of apoptoic neu- rons. Toxicol Sci,2004,81 (2) :364-370.
3Fredriksson A, Archer T, Aim H, et al. Neurofunctional deficits and potentiated apoptosis by neonatal NMDA agtagonist administra- tion. Behav Brain Res,2004,153(2) :367-376.
4Fredriksson A, Poten E, Gordh T, et al. Neonatal exposure to a combination of N-methyl-D-aspartate and gamma aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegener- ation and persistent Behavioral deficits. Anesthesioloty, 2007,107 (3) :427-436.
5Majewski-Tiedeken CR, Rabin CR, Siegel SJ. Ketamine exposure in adult mice leads to increased cell death in C2 h, DBA2 and FVB inbred mouse strains. Drug Alcohol Depend, 2008, 92 ( 1-3 ) : 217-227.
6Ming GL, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neuresci ,2005,28:223-250.
7Slikker W Jr, Zou X, Hotchkiss CE, et al. Ketamine-induced neu- renal cell death in the perinatal rhesus monkey. Toxicol Sci,2007, 98 ( 1 ) : 145-158.
8Janz R, Sudhof TC, Hammer RE, et al. Essential roles in synaptie plasticity for synaptogyrin 1 and synaptophysin 1. Neuron, 1999,24 (3) :687-700.
9Yamauchi T. Neuronal protein kinsse discovery, progress in a quar- ter of a century, and perspective : implication for learning and mem- ory. Bilo Pharm Bull, 2005,28(8) :1342-1354.
10Lu LX, Yon JH, Carter LB, et al. General anesthesis aetives BD- NF dependent neuroapo ptosis in the developing rat brain. Apepto- sis, 2006,11(9) :1603-1615.
